Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Substance Use and Immunity in HIV+ Adolescents by Systems Biology.

ABSTRACT: Substance Use and Immunity in HIV+ Adolescents by Systems Biology.

PROVIDER: PRJNA671283 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Substance Use and Immunity in HIV+ Adolescents by Systems Biology.

Project description:Substance Use and Immunity in HIV+ Adolescents by Systems Biology.

| PRJNA671282 | ENA

Extracellular Vesicle Proteomics in Substance Use Disorder

Project description:This study investigates the proteomic composition of extracellular vesicles (EVs) derived from postmortem prefrontal cortex brain tissues of individuals with substance use disorder (SUD) and matched controls.

2025-05-14 | PXD061471 | Pride

Genomics of Substance Use Disorders in Latin American Populations

Project description:Genomics of Substance Use Disorders in Latin American Populations

| PRJNA1078494 | ENA

Genomics of Substance Use Disorders in Latin American Populations

Project description:Genomics of Substance Use Disorders in Latin American Populations

| PRJNA1078495 | ENA

Methamphetamine and Other Substance Use Disorder Genetics in Thailand

Project description:Methamphetamine and Other Substance Use Disorder Genetics in Thailand

| PRJNA955367 | ENA

Analysis of association between LPHN3 markers and substance use disorder

Project description:Analysis of association between LPHN3 markers and substance use disorder

| PRJNA448611 | ENA

Proteomics of Substance Use Disorder in the Dorsolateral Prefrontal Cortex

Project description:Ex vivo large-scale proteomic analysis using LC-MS/MS in postmortem brains of patients with substance use disorder and controls. Brain tissue was collected postmortem after consent from the next of kin. As part of the clinical information, medical records were obtained and a detailed psychological autopsy was performed on all participants by interviewing the next-of-kin. Information regarding the psychiatric clinical phenotypes (evidence of depression, mania, and psychosis) stressful life events, age of drug use onset, types of drugs used, smoking and drinking history, and any co-morbidities, was obtained. A diagnosis of substance use disorder was confirmed based on the psychological autopsy, detailed medical records, and review of all relevant case information by three psychiatrists at a consensus meeting. The cause of death was obtained from the medical examiner’s report and toxicological findings after death.

2021-09-10 | PXD025269 | Pride

Genetic analysis of Substance Use Disorder using the Indiana Biobank data

Project description:Genetic analysis of Substance Use Disorder using the Indiana Biobank data

| PRJNA869819 | ENA

Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

Project description:Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

| PRJNA671286 | ENA

Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

Project description:Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

| PRJNA671287 | ENA